Clinical trial
Evaluation of Neurocognitive Performance, Quality of Life, and Emotional State in Drug Substituted Patients (Methadone, Buprenorphine, Suboxone) Under Hepatitis C Therapy (Peginterferon Alfa and Ribavirin)
NCT00682591 is registered in ClinicalTrials.gov with University of Wuerzburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Neurocognitive Performance, Quality of Life, and Emotional State in Drug Substituted Patients (Methadone, Buprenorphine, Suboxone) Under Hepatitis C Therapy (Peginterferon Alfa and Ribavirin)
- Lead sponsor
- University of Wuerzburg
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- July 31, 2008
- Completion date
- December 31, 2011
- Enrollment
- 190 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hepatitis c infection